Cargando…
A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Momordica charantia L. fruit extracts in the type 2 diabetic subjects
BACKGROUND: The fruits of Momordica charantia L., also named as bitter gourd or bitter melon in popular, is a common tropical vegetable that is traditionally used to reduce blood glucose. A peptide derived from bitter gourd, Momordica charantia insulin receptor binding peptid-19 (mcIRBP-19), had bee...
Autores principales: | Yang, Yi-Sun, Wu, Nian-Yi, Kornelius, Edy, Huang, Chien-Ning, Yang, Nae-Cherng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788657/ https://www.ncbi.nlm.nih.gov/pubmed/35140559 http://dx.doi.org/10.29219/fnr.v66.3685 |
Ejemplares similares
-
mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients’ Blood Sugar Levels
por: Hsu, Pang-Kuei, et al.
Publicado: (2020) -
Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022) -
ENZYMATIC ACTIVITY OF MOMORDICA CHARANTIA FRUITS
por: Bhuvaneshwari, D.S., et al.
Publicado: (2002) -
Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)
por: Mahwish, et al.
Publicado: (2017) -
Real-Time Quantitative PCR Analysis of the Expression Pattern of the Hypoglycemic Polypeptide-P Gene in Momordica charantia
por: Wang, Yi-Shuai, et al.
Publicado: (2019)